Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 122 entries
Sorted by: Best Match Show Resources per page
A new method for deriving trace gas emission inventories from satellite observations: The case of SO.

The Science of the total environment

Kourtidis K, Georgoulias AK, Mijling B, van der A R, Zhang Q, Ding J.
PMID: 28886544
Sci Total Environ. 2018 Jan 15;612:923-930. doi: 10.1016/j.scitotenv.2017.08.313. Epub 2017 Sep 05.

A method is developed that allows the construction of spatial emission inventories. The method is applied for anthropogenic SO

Cite
Kourtidis K, Georgoulias AK, Mijling B, et al. A new method for deriving trace gas emission inventories from satellite observations: The case of SO. Sci Total Environ. 2017;612:923-930doi: 10.1016/j.scitotenv.2017.08.313.
Kourtidis, K., Georgoulias, A. K., Mijling, B., van der A, R., Zhang, Q., & Ding, J. (2018). A new method for deriving trace gas emission inventories from satellite observations: The case of SO. The Science of the total environment, 612923-930. https://doi.org/10.1016/j.scitotenv.2017.08.313
Kourtidis, Konstantinos, et al. "A new method for deriving trace gas emission inventories from satellite observations: The case of SO." The Science of the total environment vol. 612 (2018): 923-930. doi: https://doi.org/10.1016/j.scitotenv.2017.08.313
Kourtidis K, Georgoulias AK, Mijling B, van der A R, Zhang Q, Ding J. A new method for deriving trace gas emission inventories from satellite observations: The case of SO. Sci Total Environ. 2018 Jan 15;612:923-930. doi: 10.1016/j.scitotenv.2017.08.313. Epub 2017 Sep 05. PMID: 28886544.
Copy Download .nbib Format: NLM
Evolution and Critics on "Capnography as an Aid in Localizing the Phrenic Nerve in Brachial Plexus Surgery. Technical Note" by Combined Ventilator Waveforms Analysis.

Journal of brachial plexus and peripheral nerve injury

Georgoulis G, Papagrigoriou E, Sindou M.
PMID: 29093745
J Brachial Plex Peripher Nerve Inj. 2017 Oct 30;12(1):e15-e16. doi: 10.1055/s-0037-1608623. eCollection 2017 Jan.

No abstract available.

Cite
Georgoulis G, Papagrigoriou E, Sindou M. Evolution and Critics on "Capnography as an Aid in Localizing the Phrenic Nerve in Brachial Plexus Surgery. Technical Note" by Combined Ventilator Waveforms Analysis. J Brachial Plex Peripher Nerve Inj. 2017;12(1):e15-e16doi: 10.1055/s-0037-1608623.
Georgoulis, G., Papagrigoriou, E., & Sindou, M. (2017). Evolution and Critics on "Capnography as an Aid in Localizing the Phrenic Nerve in Brachial Plexus Surgery. Technical Note" by Combined Ventilator Waveforms Analysis. Journal of brachial plexus and peripheral nerve injury, 12(1), e15-e16. https://doi.org/10.1055/s-0037-1608623
Georgoulis, George, et al. "Evolution and Critics on "Capnography as an Aid in Localizing the Phrenic Nerve in Brachial Plexus Surgery. Technical Note" by Combined Ventilator Waveforms Analysis." Journal of brachial plexus and peripheral nerve injury vol. 12,1 (2017): e15-e16. doi: https://doi.org/10.1055/s-0037-1608623
Georgoulis G, Papagrigoriou E, Sindou M. Evolution and Critics on "Capnography as an Aid in Localizing the Phrenic Nerve in Brachial Plexus Surgery. Technical Note" by Combined Ventilator Waveforms Analysis. J Brachial Plex Peripher Nerve Inj. 2017 Oct 30;12(1):e15-e16. doi: 10.1055/s-0037-1608623. eCollection 2017 Jan. PMID: 29093745; PMCID: PMC5662466.
Copy Download .nbib Format: NLM
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kouroussis Ch, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V.
PMID: 17335131
J BUON. 2005 Jan-Mar;10(1):47-52.

PURPOSE: A phase II study was conducted to evaluate the toxicity and efficacy of irinotecan (CPT-11), 5-fluorouracil/leucovorin (5-FU/LV) (AIO regimen) as salvage treatment in patients with metastatic colorectal cancer (MCC).PATIENTS AND METHODS: Thirty-three patients relapsing after oxaliplatin-based first line...

Cite
Souglakos J, Vardakis N, Androulakis N, et al. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. J BUON. 2005;10(1):47-52
Souglakos, J., Vardakis, N., Androulakis, N., Kakolyris, S., Kouroussis, C. h., Mavroudis, D., Pallis, A., Agelaki, S., Kalbakis, K., & Georgoulias, V. (2005). Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 10(1), 47-52.
Souglakos, J, et al. "Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial." Journal of B.U.ON. : official journal of the Balkan Union of Oncology vol. 10,1 (2005): 47-52.
Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kouroussis Ch, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. J BUON. 2005 Jan-Mar;10(1):47-52. PMID: 17335131.
Copy Download .nbib Format: NLM
Grammatical Evolution for Features of Epileptic Oscillations in Clinical Intracranial Electroencephalograms.

Expert systems with applications

Smart O, Tsoulos IG, Gavrilis D, Georgoulas G.
PMID: 21607200
Expert Syst Appl. 2011 Aug 01;38(8):9991-9999. doi: 10.1016/j.eswa.2011.02.009.

This paper presents grammatical evolution (GE) as an approach to select and combine features for detecting epileptic oscillations within clinical intracranial electroencephalogram (iEEG) recordings of patients with epilepsy. Clinical iEEG is used in preoperative evaluations of a patient who...

Cite
Smart O, Tsoulos IG, Gavrilis D, et al. Grammatical Evolution for Features of Epileptic Oscillations in Clinical Intracranial Electroencephalograms. Expert Syst Appl. 2011;38(8):9991-9999doi: 10.1016/j.eswa.2011.02.009.
Smart, O., Tsoulos, I. G., Gavrilis, D., & Georgoulas, G. (2011). Grammatical Evolution for Features of Epileptic Oscillations in Clinical Intracranial Electroencephalograms. Expert systems with applications, 38(8), 9991-9999. https://doi.org/10.1016/j.eswa.2011.02.009
Smart, Otis, et al. "Grammatical Evolution for Features of Epileptic Oscillations in Clinical Intracranial Electroencephalograms." Expert systems with applications vol. 38,8 (2011): 9991-9999. doi: https://doi.org/10.1016/j.eswa.2011.02.009
Smart O, Tsoulos IG, Gavrilis D, Georgoulas G. Grammatical Evolution for Features of Epileptic Oscillations in Clinical Intracranial Electroencephalograms. Expert Syst Appl. 2011 Aug 01;38(8):9991-9999. doi: 10.1016/j.eswa.2011.02.009. PMID: 21607200; PMCID: PMC3098450.
Copy Download .nbib Format: NLM
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials.

BMJ open

Laporte S, Squifflet P, Baroux N, Fossella F, Georgoulias V, Pujol JL, Douillard JY, Kudoh S, Pignon JP, Quinaux E, Buyse M.
PMID: 23485717
BMJ Open. 2013 Mar 13;3(3). doi: 10.1136/bmjopen-2012-001802.

OBJECTIVES: To investigate whether progression-free survival (PFS) can be considered a surrogate endpoint for overall survival (OS) in advanced non-small-cell lung cancer (NSCLC).DESIGN: Meta-analysis of individual patient data from randomised trials.SETTING: Five randomised controlled trials comparing docetaxel-based chemotherapy with...

Cite
Laporte S, Squifflet P, Baroux N, et al. Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials. BMJ Open. 2013;3(3)doi: 10.1136/bmjopen-2012-001802.
Laporte, S., Squifflet, P., Baroux, N., Fossella, F., Georgoulias, V., Pujol, J. L., Douillard, J. Y., Kudoh, S., Pignon, J. P., Quinaux, E., & Buyse, M. (2013). Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials. BMJ open, 3(3), . https://doi.org/10.1136/bmjopen-2012-001802
Laporte, Silvy, et al. "Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials." BMJ open vol. 3,3 (2013). doi: https://doi.org/10.1136/bmjopen-2012-001802
Laporte S, Squifflet P, Baroux N, Fossella F, Georgoulias V, Pujol JL, Douillard JY, Kudoh S, Pignon JP, Quinaux E, Buyse M. Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials. BMJ Open. 2013 Mar 13;3(3). doi: 10.1136/bmjopen-2012-001802. PMID: 23485717; PMCID: PMC3612819.
Copy Download .nbib Format: NLM
Optical properties of alpha -SiC:H thin films grown by rf sputtering.

Physical review. B, Condensed matter

Georgoulas N, Kalomiros JA, Logothetidis S, Magafas L, Papadopoulos A, Thanailakis A.
PMID: 10009585
Phys Rev B Condens Matter. 1994 Mar 15;49(12):8191-8197. doi: 10.1103/physrevb.49.8191.

No abstract available.

Cite
Georgoulas N, Kalomiros JA, Logothetidis S, et al. Optical properties of alpha -SiC:H thin films grown by rf sputtering. Phys Rev B Condens Matter. 1994;49(12):8191-8197doi: 10.1103/physrevb.49.8191.
Georgoulas, N., Kalomiros, J. A., Logothetidis, S., Magafas, L., Papadopoulos, A., & Thanailakis, A. (1994). Optical properties of alpha -SiC:H thin films grown by rf sputtering. Physical review. B, Condensed matter, 49(12), 8191-8197. https://doi.org/10.1103/physrevb.49.8191
Georgoulas, et al. "Optical properties of alpha -SiC:H thin films grown by rf sputtering." Physical review. B, Condensed matter vol. 49,12 (1994): 8191-8197. doi: https://doi.org/10.1103/physrevb.49.8191
Georgoulas N, Kalomiros JA, Logothetidis S, Magafas L, Papadopoulos A, Thanailakis A. Optical properties of alpha -SiC:H thin films grown by rf sputtering. Phys Rev B Condens Matter. 1994 Mar 15;49(12):8191-8197. doi: 10.1103/physrevb.49.8191. PMID: 10009585.
Copy Download .nbib Format: NLM
Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group.

Annals of gastroenterology

Kentepozidis N, Economopoulou P, Liontos M, Kotsakis A, Boukovinas I, Vardakis N, Kontopodis E, Prinarakis E, Skaltsi T, Souglakos J, Georgoulias V.
PMID: 30386120
Ann Gastroenterol. 2018 Nov-Dec;31(6):698-704. doi: 10.20524/aog.2018.0311. Epub 2018 Sep 14.

BACKGROUND: A phase I/II study to define the maximum tolerated dose (MTD) of biweekly docetaxel/cisplatin/5-fluorouracil (DCF) plus panitumumab (P), its efficacy, and tolerability as first-line treatment in advanced gastroesophageal cancer.METHODS: In phase I part, patients with unresectable locally advanced...

Cite
Kentepozidis N, Economopoulou P, Liontos M, et al. Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Ann Gastroenterol. 2018;31(6):698-704doi: 10.20524/aog.2018.0311.
Kentepozidis, N., Economopoulou, P., Liontos, M., Kotsakis, A., Boukovinas, I., Vardakis, N., Kontopodis, E., Prinarakis, E., Skaltsi, T., Souglakos, J., & Georgoulias, V. (2018). Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Annals of gastroenterology, 31(6), 698-704. https://doi.org/10.20524/aog.2018.0311
Kentepozidis, Nikolaos, et al. "Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group." Annals of gastroenterology vol. 31,6 (2018): 698-704. doi: https://doi.org/10.20524/aog.2018.0311
Kentepozidis N, Economopoulou P, Liontos M, Kotsakis A, Boukovinas I, Vardakis N, Kontopodis E, Prinarakis E, Skaltsi T, Souglakos J, Georgoulias V. Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group. Ann Gastroenterol. 2018 Nov-Dec;31(6):698-704. doi: 10.20524/aog.2018.0311. Epub 2018 Sep 14. PMID: 30386120; PMCID: PMC6191861.
Copy Download .nbib Format: NLM
Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer.

Translational oncology

Matikas A, Voutsina A, Lagoudaki E, Hatzidaki D, Trypaki M, Stoupis G, Tzardi M, Mavroudis D, Georgoulias V.
PMID: 28692881
Transl Oncol. 2017 Aug;10(4):693-698. doi: 10.1016/j.tranon.2017.06.005. Epub 2017 Jul 07.

INTRODUCTION: The presence of KRAS mutations in patients with metastatic colorectal cancer (mCRC) predicts poor response to agents targeting the EGFR. Even in patients with RAS wild type (WT) tumors, resistance eventually develops due to multiple mechanisms, including the...

Cite
Matikas A, Voutsina A, Lagoudaki E, et al. Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Transl Oncol. 2017;10(4):693-698doi: 10.1016/j.tranon.2017.06.005.
Matikas, A., Voutsina, A., Lagoudaki, E., Hatzidaki, D., Trypaki, M., Stoupis, G., Tzardi, M., Mavroudis, D., & Georgoulias, V. (2017). Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Translational oncology, 10(4), 693-698. https://doi.org/10.1016/j.tranon.2017.06.005
Matikas, Alexios, et al. "Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer." Translational oncology vol. 10,4 (2017): 693-698. doi: https://doi.org/10.1016/j.tranon.2017.06.005
Matikas A, Voutsina A, Lagoudaki E, Hatzidaki D, Trypaki M, Stoupis G, Tzardi M, Mavroudis D, Georgoulias V. Detection of KRAS Exon 2 Mutations in Circulating Tumor Cells Isolated by the ISET System from Patients with RAS Wild Type Metastatic Colorectal Cancer. Transl Oncol. 2017 Aug;10(4):693-698. doi: 10.1016/j.tranon.2017.06.005. Epub 2017 Jul 07. PMID: 28692881; PMCID: PMC5503828.
Copy Download .nbib Format: NLM
Unbiased Bayesian inference for population Markov jump processes via random truncations.

Statistics and computing

Georgoulas A, Hillston J, Sanguinetti G.
PMID: 28690370
Stat Comput. 2017;27(4):991-1002. doi: 10.1007/s11222-016-9667-9. Epub 2016 Jun 02.

We consider continuous time Markovian processes where populations of individual agents interact stochastically according to kinetic rules. Despite the increasing prominence of such models in fields ranging from biology to smart cities, Bayesian inference for such systems remains challenging,...

Cite
Georgoulas A, Hillston J, Sanguinetti G. Unbiased Bayesian inference for population Markov jump processes via random truncations. Stat Comput. 2016;27(4):991-1002doi: 10.1007/s11222-016-9667-9.
Georgoulas, A., Hillston, J., & Sanguinetti, G. (2017). Unbiased Bayesian inference for population Markov jump processes via random truncations. Statistics and computing, 27(4), 991-1002. https://doi.org/10.1007/s11222-016-9667-9
Georgoulas, Anastasis, et al. "Unbiased Bayesian inference for population Markov jump processes via random truncations." Statistics and computing vol. 27,4 (2017): 991-1002. doi: https://doi.org/10.1007/s11222-016-9667-9
Georgoulas A, Hillston J, Sanguinetti G. Unbiased Bayesian inference for population Markov jump processes via random truncations. Stat Comput. 2017;27(4):991-1002. doi: 10.1007/s11222-016-9667-9. Epub 2016 Jun 02. PMID: 28690370; PMCID: PMC5477715.
Copy Download .nbib Format: NLM
The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update.

Expert review of respiratory medicine

Matikas A, Georgoulias V, Kotsakis A.
PMID: 27661451
Expert Rev Respir Med. 2016 Nov;10(11):1229-1241. doi: 10.1080/17476348.2016.1240620. Epub 2016 Oct 03.

INTRODUCTION: Non-small cell lung cancer lung cancer (NSCLC) is a devastating disease, with poor prognosis for patients with metastatic disease. The management of these patients has evolved during the past decade, challenging the role of cytotoxic chemotherapy as the...

Cite
Matikas A, Georgoulias V, Kotsakis A. The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update. Expert Rev Respir Med. 2016;10(11):1229-1241doi: 10.1080/17476348.2016.1240620.
Matikas, A., Georgoulias, V., & Kotsakis, A. (2016). The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update. Expert review of respiratory medicine, 10(11), 1229-1241. https://doi.org/10.1080/17476348.2016.1240620
Matikas, A, et al. "The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update." Expert review of respiratory medicine vol. 10,11 (2016): 1229-1241. doi: https://doi.org/10.1080/17476348.2016.1240620
Matikas A, Georgoulias V, Kotsakis A. The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update. Expert Rev Respir Med. 2016 Nov;10(11):1229-1241. doi: 10.1080/17476348.2016.1240620. Epub 2016 Oct 03. PMID: 27661451.
Copy Download .nbib Format: NLM
Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Valotassiou V, Angelidis G, Alexiou S, Psimadas D, Tsougos I, Georgoulias P.
PMID: 31579358
Indian J Nucl Med. 2019 Oct-Dec;34(4):324-325. doi: 10.4103/ijnm.IJNM_115_19.

A 50-year-old man with beta-thalassemia major underwent Tc-99m sestamibi parathyroid scintigraphy due to elevated parathyroid hormone and calcium serum levels. Single-photon emission computed tomography imaging of neck and thorax revealed a parathyroid adenoma, as well as increased tracer uptake...

Cite
Valotassiou V, Angelidis G, Alexiou S, et al. Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy. Indian J Nucl Med. 2019;34(4):324-325doi: 10.4103/ijnm.IJNM_115_19.
Valotassiou, V., Angelidis, G., Alexiou, S., Psimadas, D., Tsougos, I., & Georgoulias, P. (2019). Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 34(4), 324-325. https://doi.org/10.4103/ijnm.IJNM_115_19
Valotassiou, Varvara, et al. "Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy." Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India vol. 34,4 (2019): 324-325. doi: https://doi.org/10.4103/ijnm.IJNM_115_19
Valotassiou V, Angelidis G, Alexiou S, Psimadas D, Tsougos I, Georgoulias P. Detection of Extramedullary Hematopoietic Tissue in a Patient with Beta-Thalassemia Major on Tc99m-Sestamibi Parathyroid Scintigraphy. Indian J Nucl Med. 2019 Oct-Dec;34(4):324-325. doi: 10.4103/ijnm.IJNM_115_19. PMID: 31579358; PMCID: PMC6771193.
Copy Download .nbib Format: NLM
Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340.

Annals of oncology : official journal of the European Society for Medical Oncology

Mavroudis D, Saloustros E, Malamos N, Kakolyris S, Boukovinas I, Papakotoulas P, Kentepozidis N, Ziras N, Georgoulias V.
PMID: 32067691
Ann Oncol. 2020 Mar;31(3):444-445. doi: 10.1016/j.annonc.2020.01.004. Epub 2020 Jan 31.

No abstract available.

Cite
Mavroudis D, Saloustros E, Malamos N, et al. Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340. Ann Oncol. 2020;31(3):444-445doi: 10.1016/j.annonc.2020.01.004.
Mavroudis, D., Saloustros, E., Malamos, N., Kakolyris, S., Boukovinas, I., Papakotoulas, P., Kentepozidis, N., Ziras, N., Georgoulias, V. (2020). Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340. Annals of oncology : official journal of the European Society for Medical Oncology, 31(3), 444-445. https://doi.org/10.1016/j.annonc.2020.01.004
Mavroudis, D, et al. "Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340." Annals of oncology : official journal of the European Society for Medical Oncology vol. 31,3 (2020): 444-445. doi: https://doi.org/10.1016/j.annonc.2020.01.004
Mavroudis D, Saloustros E, Malamos N, Kakolyris S, Boukovinas I, Papakotoulas P, Kentepozidis N, Ziras N, Georgoulias V. Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG): Annals of Oncology, Volume 26, Issue 7, July 2015, Pages 1333-1340. Ann Oncol. 2020 Mar;31(3):444-445. doi: 10.1016/j.annonc.2020.01.004. Epub 2020 Jan 31. PMID: 32067691.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 122 entries